Immunological and Histological Evaluation of Specific Immunotherapy With Recombinant Hypoallergenic Derivative
Clinical trial NCT00841516 · COMPLETED
Trial details
- NCT number
- NCT00841516
- Sponsor
- Allergopharma GmbH & Co. KG
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2007-12-01
- Primary completion
- 2011-04-01
- Enrollment
- 14
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.